Product Comparison
Compare the three berberine formats head-to-head — the trial-dose standard, the pharmacokinetic-boosted reduced form, and the efflux-blocked Italian combination. In berberine's comparison, the honest principle is: the molecule is a pharmacologically active player with an absorption problem and an interaction profile — the form is the promise, the outcomes are still the standard's.
At a glance
Berberine HCl 500 mg
Dihydroberberine 100 mg
Berberine + Silymarin (500 mg + Complex)
Multi-dimensional comparison
Multi-dimensional Comparison
| Metric | 🏆Berberine HCl 500 mg Various (USP-grade berberine hydrochloride) | Dihydroberberine 100 mg Various (dihydroberberine standardized) | Berberine + Silymarin (500 mg + Complex) Various (the Italian-combination formulation family) |
|---|---|---|---|
| Delivery Form | Capsule | Capsule | Tablet |
| Strength | 500 mg berberine hydrochloride | 100 mg dihydroberberine per capsule | 500 mg berberine HCl + silymarin (milk thistle extract) per tablet |
| Servings / Container | 60 | 60 | 60 |
| Retail Price | $19.99 | $29.99 | $34.99 |
| Cost / Serving | $0.33BEST 💰 | $0.50 | $0.58 |
| Overall Score | 78/100 | 70/100 | 74/100 |
| 3rd-Party Testing | None | None | None |
| Vegan Friendly | ✓ Yes | ✓ Yes | — No |
Did you know?
The pooled HbA1c effect
The marker effect the entire category is built on — real, replicated in pooled analyses, and the number to hold against any claim. It is metformin's neighborhood on markers; it is not metformin's evidence class, and the outcomes gap is the comparison that matters most.
The outcome trials
No cardiovascular endpoint, no complication prevention, no mortality data — the difference between this molecule and the drug it rhymes with. Marker trials guide hypotheses; outcome trials define drugs. Berberine has the first, awaits the second, and the aisle sells the third.
The absorption ceiling
P-glycoprotein efflux and first-pass metabolism keep nearly all of an oral dose in the gut — where the microbiome seat lives. The form frontier (dihydroberberine's ~5× exposure, silymarin's pump blockade) routes around the ceiling; the outcomes still belong to the standard form's trials.
The interaction set
CYP2D6, 2C9, 3A4, and P-glycoprotein — a genuine drug-interaction profile with documented cyclosporine elevations and hypoglycemia-stacking risk with diabetes drugs. The physician-before-first-capsule rule is the comparison's standing first line.
The pregnancy line
Placental transfer, uterotonic potential, and neonatal kernicterus risk (bilirubin displacement): berberine is absolutely contraindicated in pregnancy and not for nursing newborns or infants — one of the few lines this library draws without softening.
The weight reality
The pooled weight effect the 'nature's Ozempic' summer ignored — an order of magnitude from the GLP-1 class it was compared to. Modest, real, and nowhere near the headline that emptied the shelves in 2023.